Amniotic Membrane Market Report 2026

The amniotic membrane market size has grown rapidly in recent years. It will grow from $1.88 billion in 2025 to $2.09 billion in 2026 at a compound annual growth rate (CAGR) of 10.8%. The growth in the historic period can be attributed to expansion of regenerative medicine research, increasing surgical wound management needs, adoption in ophthalmology practices, availability of tissue preservation technologies, growth of hospital-based biologic treatments.

The amniotic membrane market size is expected to see rapid growth in the next few years. It will grow to $3.15 billion in 2030 at a compound annual growth rate (CAGR) of 10.9%. The growth in the forecast period can be attributed to increasing demand for advanced wound healing solutions, rising use in minimally invasive surgeries, expansion of outpatient surgical procedures, growing focus on biologic-based therapies, increasing regulatory clarity for tissue-based products. Major trends in the forecast period include increasing use of amniotic membranes in regenerative therapies, rising adoption in ophthalmic procedures, expansion of wound care applications, growing demand for cryopreserved products, enhanced focus on biologic safety standards.

The rising level of transplant activity is expected to drive the growth of the amniotic membrane market going forward. Transplantation involves the surgical transfer of tissues or organs from a donor to a recipient and frequently incorporates amniotic membranes in surgical and reconstructive procedures to support tissue repair and recovery. The growth in transplant activity is driven by factors such as increased awareness of organ donation, advancements in surgical techniques, and improved donor-recipient matching processes. Amniotic membrane allografts aid post-transplant healing by providing a biologically active extracellular matrix and regulatory proteins that promote tissue regeneration. For instance, in January 2024, according to the Organ Procurement and Transplantation Network (OPTN), a US-based organization that manages the national organ transplant system, the United States recorded 46,632 total organ transplants in 2023, representing an 8.7% increase from 2022, along with 41,119 deceased-donor transplants in 2024, reflecting a further 3.6% increase over 2023. Therefore, the rising transplant activity is contributing to the growth of the amniotic membrane market.

The increasing prevalence of chronic diseases is expected to propel the growth of the amniotic membrane market going forward. Chronic diseases are conditions that persist for three months or longer and often worsen over time. The unique properties of amniotic membranes, including anti-inflammatory and regenerative characteristics, make them valuable in managing chronic conditions, reducing complications, and addressing tissue damage. Their versatility enables application across multiple medical specialties, supporting the demand for effective therapeutic solutions associated with chronic disease management. For instance, in February 2024, according to the World Health Organization, a Switzerland-based United Nations agency, it is projected that more than 35 million new cancer cases will occur by 2050, representing a 77% increase compared to the estimated 20 million cases in 2022. Therefore, the growing prevalence of chronic diseases is driving the expansion of the amniotic membrane market.

Major companies operating in the amniotic membrane market are concentrating on the development of advanced allograft products to enhance patient care and clinical outcomes. Amniotic membrane allografts are derived from the innermost layer of the placenta and are used to treat ocular and surgical wounds by providing a natural extracellular matrix and growth factors that support healing. For example, in December 2024, BioTissue, a US-based biotechnology company, launched CAM360 AmnioGraft (CAM360 AG), a ringless, shelf-stable cryopreserved amniotic membrane designed for the treatment of mild to moderate dry eye and early-stage neurotrophic keratitis. The product provides eye care professionals with flexible application options, including use beneath a bandage contact lens or with a collagen shield, and enables rapid symptom relief within 48 hours. CAM360 AG broadens available treatment options while simplifying inventory management for clinical settings, thereby supporting growth in the amniotic membrane market.

Major companies operating in the amniotic membrane market are MiMedx Group Inc, Organogenesis Holdings Inc, Amnio Technology LLC, Applied Biologics LLC, Human Regenerative Technologies LLC, Skye Biologics Inc, Amniox Medical Inc, Bio-Tissue Inc, TissueTech Inc, Osiris Therapeutics Inc, VIVEX Biologics Inc, Merakris Therapeutics Inc, Celularity Inc, BioLab Sciences, LifeCell International Pvt. Ltd., FzioMed Inc, Corza Ophthalmology, Integra LifeSciences Co, Smith & Nephew, RTI Surgical.

North America was the largest region in the amniotic membrane market share in 2025.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the amniotic membrane market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the amniotic membrane market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the amniotic membrane market by increasing costs of imported preservation equipment, sterilization materials, cold-chain logistics systems, and processing technologies used in biologic tissue preparation. Hospitals and surgical centers in North America and Europe are most affected due to reliance on imported processing inputs, while Asia-Pacific faces cost pressure on export-oriented biologic products. These tariffs are increasing product pricing and limiting access in cost-sensitive settings. However, they are also encouraging domestic tissue banking, localized processing facilities, and regional supply chain development for amniotic membrane products.

The amniotic membrane market research report is one of a series of new reports that provides amniotic membrane market statistics, including amniotic membrane industry global market size, regional shares, competitors with a amniotic membrane market share, detailed amniotic membrane market segments, market trends and opportunities, and any further data you may need to thrive in the amniotic membrane industry. This amniotic membrane market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The amniotic membrane is the innermost layer of the placenta, composed of an avascular stromal matrix and a thick basement membrane. It has multiple applications in regenerative medicine and is commonly used as a surgical dressing across various subspecialties to promote wound healing and reduce inflammation.

The main forms of amniotic membrane products include cryopreserved amniotic membrane and lyophilized amniotic membrane. Lyophilized amniotic membrane is prepared through a process of rapid freezing followed by a vacuum that removes ice, preserving the tissue. These products are applied in areas such as surgical wounds, ophthalmology, and other medical applications, and are utilized in hospitals, ambulatory surgical centers (ASCs), specialty clinics, as well as research and academic institutions.

The amniotic membrane market consists of sales of epithelium, basement membrane, and stroma. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.